Search Results for citation:"90 FR 2006"

Found 2 results

Search Results: citation:"90 FR 2006"

💰 Only
Oldest Newest
  • 2025-00262 — Amendment of the Statement of Organizations, Functions and Delegation of Authority
    Type:Notice
    Citation:90 FR 2006
    Reading Time:about 2 minutes

    The Administration for Children and Families (ACF) announced an amendment to a previous statement from April 28, 2009. This change allows the Director of the Office of Refugee Resettlement more flexibility by enabling them to redelegate certain responsibilities assigned under the William Wilberforce Trafficking Victims Protection Reauthorization Act of 2008. The amendment is effective immediately and aims to enhance the management of these duties. All other details in the original statement remain the same.

    Simple Explanation

    The government is letting a person in charge of helping refugees share their duties with others to make things work better. But it's not very clear about how they should do that sharing, which might make it a bit confusing.

  • 2025-00341 — Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor)
    Type:Notice
    Citation:90 FR 2006
    Reading Time:about a minute or two

    The Food and Drug Administration (FDA) has announced that they approved the use of ALYFTREK, a drug made up of vanzacaftor, tezacaftor, and deutivacaftor, on December 20, 2024. This approval includes the use of a priority review voucher, which is a special designation given to sponsors of drugs for rare pediatric diseases. These vouchers are part of a program designed to encourage the development of treatments for rare conditions found in children. For more information, individuals can visit the FDA's official website linked in the document.

    Simple Explanation

    The FDA has said "yes" to a new medicine called ALYFTREK that helps kids with rare illnesses, and they're using a special ticket to get it approved faster. Think of the ticket as a "skip the line" pass at a theme park to help the medicine get to kids who need it more quickly.